The epithelial-mesenchymal transition of colon carcinoma involves expression of IL-8 and CXCR-1-mediated chemotaxis

被引:116
作者
Bates, RC
DeLeo, MJ
Mercurio, AM
机构
[1] Beth Israel Deaconess Med Ctr, Dept Pathol, Div Canc Biol & Angiogenesis, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA 02215 USA
关键词
cytokine; interleukin-8; tumor progression; colon carcinoma; migration; autocrine signaling;
D O I
10.1016/j.yexcr.2004.05.033
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The epithelial-mesenchymal transition (EMT) is an essential component of embryonic development, tissue remodeling, and wound repair. In addition, many epithelial tumors, including colorectal carcinomas, appear to undergo this transition that may facilitate their invasion. Using a novel model of EMT in colon carcinoma in which the inflammatory cytokine TNF-alpha accelerates this TGF-beta directed process, we report that TNF-alpha stimulation upregulates expression of the chemokine IL-8, and that this upregulation is dependent on the transcription factor NF-kappaB. Significantly, this effect is not merely an inflammatory response by these colon carcinoma cells because IL-8 expression is induced in cells undergoing a TGF-beta-driven EMT in the absence of exogenous TNF-alpha. During the EMT, a concomitant increase in the chemokine receptor CXCR-1, but not CXCR-2, also occurs. Moreover, both IL-8 and CXCR-1 function in the chemokinetic and chemotactic migration of colon carcinoma cells as assessed by antibody inhibition studies. These studies establish that the regulated expression of a specific chemokine and its receptor are linked to the EMT and they provide a biochemical framework for understanding the mechanisms by which the EMT promotes migration. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:315 / 324
页数:10
相关论文
共 47 条
  • [1] ABREUMARTIN MT, 1995, J IMMUNOL, V155, P4147
  • [2] The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity
    Addison, CL
    Daniel, TO
    Burdick, MD
    Liu, H
    Ehlert, JE
    Xue, YY
    Buechi, L
    Walz, A
    Richmond, A
    Strieter, RM
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (09) : 5269 - 5277
  • [3] The CXC chemokines growth-regulated oncogene (GRO) alpha, GRO beta, GRO gamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor
    Ahuja, SK
    Murphy, PM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (34) : 20545 - 20550
  • [4] Mucosal expression of interleukin-6 and interleukin-8 messenger RNA in ulcerative colitis and in Crohn's disease
    Arai, F
    Takahashi, T
    Furukawa, K
    Matsushima, K
    Asakura, H
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (09) : 2071 - 2079
  • [5] Epithelial mesenchymal interactions in cancer and development
    Arias, AM
    [J]. CELL, 2001, 105 (04) : 425 - 431
  • [6] BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97
  • [7] APOPTOSIS INDUCED BY INHIBITION OF INTERCELLULAR CONTACT
    BATES, RC
    BURET, A
    VANHELDEN, DF
    HORTON, MA
    BURNS, GF
    [J]. JOURNAL OF CELL BIOLOGY, 1994, 125 (02) : 403 - 415
  • [8] Flt-1-dependent survival characterizes the epithelial-mesenchymal transition of colonic organoids
    Bates, RC
    Goldsmith, JD
    Bachelder, RE
    Brown, C
    Shibuya, M
    Oettgen, P
    Mercurio, AM
    [J]. CURRENT BIOLOGY, 2003, 13 (19) : 1721 - 1727
  • [9] Tumor necrosis factor-α stimulates the epithelial-to-mesenchymal transition of human colonic organoids
    Bates, RC
    Mercurio, AM
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2003, 14 (05) : 1790 - 1800
  • [10] Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro
    Brew, R
    Erikson, JS
    West, DC
    Kinsella, AR
    Slavin, J
    Christmas, SE
    [J]. CYTOKINE, 2000, 12 (01) : 78 - 85